期刊文献+

γδ T细胞与肿瘤免疫治疗 被引量:4

γδ T cells and cancer immunotherapy
原文传递
导出
摘要 γδ T细胞是一类在人体先天性和过继性免疫反应中均起重要作用的独特免疫细胞亚群。它们识别抗原不受主要组织相容性抗原限制,具有显著的肿瘤细胞杀伤作用,因此利用γδ T细胞作为抗肿瘤免疫反应的效应细胞已引起了广泛关注。现对近年γδ T细胞在肿瘤免疫治疗领域的研究,尤其是在几种常见妇科肿瘤的实验研究进行综述。 γδ T cells have been well recognized as a unique cell population that is actively involved in both innate and adoptive immunity of bodies. The features of γδ T cells, such as their major histocompatibility complex independent antigen recognition and their cytotoxic effects to tumor cells, make them as promising candidates used for cancer immunotherapy. There is a strong interest in developing γδ T cell-based immunotherapy for clinical application in treating cancer patients. This review discusses the progress of recent studies related to the γδ T cells and cancer immunotherapy, with an emphasis on the main characteristics of γδ T cells in several types of gynecologic tumors.
作者 赵雨薇 武雄飞 邹丽娟 徐晓颖 Zhao Yuwei;Wu Xiongfei;Zou Lijuan;Xu Xiaoying(Department of Radiation Oncology, the Second Hospital of Dalian Medical University, Dalian 116023, China)
出处 《中国医师进修杂志》 2018年第7期659-664,共6页 Chinese Journal of Postgraduates of Medicine
关键词 T淋巴细胞 肿瘤治疗方案 免疫疗法 综述 T-lymphocytes Antineoplastic protocols Immunotherapy Review
  • 相关文献

参考文献6

二级参考文献63

  • 1全国肿瘤防治研究办公室,卫生部卫生信息中心.中国试点市、县恶性肿瘤的发病与死亡(1993-1997).北京:中国医药科技出版社,2002.
  • 2Stewart BW,Kleihues P. World cancer report. IARC Press,Lyon,2003.
  • 3Althuis MD, Dozier JM, Anderson WF, et al. Global trends inbreast cancer incidence and mortality 197-1997. Int J Epidemiol,2005,34(2):405-412.
  • 4郝捷,赵平,陈万青.2011中国肿瘤登记年报.北京:军事医学科学出版社,2012.
  • 5陈竺.全国第三次死因回顾滿样调查报告.北京:中国协和医科大学出版社,2008.
  • 6Ferlay J,Shin HR,Bray F,et al. GLOBOCAN 2008 vl.2,CancerIncidence and Mortality Worldwide : IARC CancerBase No. 10[internet]. Lyon, France: International Agency for Research onCancer; 2010. Available from: http://glofiocan.iarc.fr,accessedon 30/10/2011.
  • 7Yang L,Parkin DM,Ferlay J,et al. Estimates of cancer incidencein China for 2000 and projections for 2005. Cancer EpidemiolBiomarkers Prev,2005,14(1) :243-250.
  • 8Zhao P, Dai M, Chen WQ, et al. Cancer trends in China. Jpn JClin Oncol,2010,40:281-285.
  • 9Madigan MP,Ziegler RG, Benichou J, et al. Proportion of breastcancer cases in the United States explained by well-establishedrisk factors. JNatl Cancer Inst, 1995,87 : 1681-1685.
  • 10Tavani A, Braga C, La Vecchia C, et al. Attributable risks forbreast cancer in Italy : education, family history and reproductiveand hormonal factors. Int J Cancer, 1997,70: 159-163.

共引文献219

同被引文献25

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部